€99.70
0.39% today
L&S, Jul 01, 05:05 pm CET
ISIN
US66987V1098
Symbol
NVS
Sector
Industry

Novartis ADR Share price

$106.46
+6.78 6.80% 1M
+6.49 6.49% 6M
+5.49 5.44% YTD
+13.27 14.24% 1Y
+19.08 21.84% 3Y
+20.02 23.16% 5Y
+20.76 24.22% 10Y
NYSE, Closing price Fri, Jun 28 2024
ISIN
US66987V1098
Symbol
NVS
Sector
Industry

Key figures

Market capitalization $208.29b
Enterprise Value $225.90b
PER (TTM) P/E ratio 14.35
EV/FCF (TTM) EV/FCF 17.77
EV/Sales (TTM) EV/Sales 4.64
P/S ratio (TTM) P/S ratio 4.28
P/B ratio (TTM) P/B ratio 5.48
Dividend yield 3.51%
Last dividend (FY24) $3.74
Sales growth (TTM) Sales growth -4.53%
Turnover (TTM) Turnover $48.66b
EBIT (operating result TTM) EBIT $13.33b
Free cash flow (TTM) Free cash flow $12.72b
Cash position $9.75b
EPS (TTM) EPS $7.42
P/E ratio expected 19.88
P/S ratio expected 4.21
EV/Sales expected 4.57
Short interest 0.26%
Show more

Is Novartis ADR a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Novartis ADR Share analysis

Unlock scores for free

Analyst opinions

28 Analysts have issued a Novartis ADR forecast:

10x Buy
36%
16x Hold
57%
2x Sell
7%

Analyst opinions

28 Analysts have issued a Novartis ADR forecast:

Buy
36%
Hold
57%
Sell
7%

Financial data from Novartis ADR

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
48,656 48,656
5% 5%
100%
- Direct costs 13,558 13,558
12% 12%
28%
35,098 35,098
1% 1%
72%
- Selling and administrative expenses 5,223 5,223
16% 16%
11%
- Research and development costs 8,707 8,707
1% 1%
18%
21,168 21,168
4% 4%
44%
- Depreciation and amortization 7,838 7,838
1% 1%
16%
EBIT (operating result) EBIT 13,330 13,330
5% 5%
27%
Net profit 15,245 15,245
117% 117%
31%

Figures in millions USD.

Don't miss a thing! We will send you all news about the Novartis ADR share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Novartis ADR Share News

Positive
Seeking Alpha
2 days ago
The market remains near record highs with the best-ever presidential election year return and 13th-best S&P return through the first half of the year. Free cash flow yield is the best valuation metric since 1990, averaging 17.6% annual returns for the most undervalued companies over the last 33 years. Screening for high free cash flow yield dividend aristocrats can provide a diversified portfol...
Positive
Seeking Alpha
9 days ago
Stocks have been on fire since October lows, with many investors worried about bubbles and looming corrections. Even with the market at an all-time high, there are always extraordinary blue-chip bargains to buy. Optimal portfolio design with 11 sector Ultra SWAN blue-chip max volatility-adjusted return potential can provide good returns and lower volatility in bear markets.
Positive
InvestorPlace
14 days ago
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing is more valuable than one's health.
More Novartis ADR News

Company profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Vasant Narasimhan
Employees 76,057
Founded 1996
Website www.novartis.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now